
Sign up to save your podcasts
Or


A high-yield breakdown of Clostridioides difficile, focusing on the hypervirulent Ribotype 027 strain driving increased hospital morbidity. The episode details the clinical shift away from metronidazole to oral vancomycin or fidaxomicin, and the surprising paradox that mechanical bowel prep with oral antibiotics actually reduces postoperative CDI risk. For surgical management of fulminant colitis, it contrasts the morbidity of the traditional total abdominal colectomy with the colon-preserving loop ileostomy and colonic lavage approach.
By Allen Kamrava, MD MBA FACS FASCRSA high-yield breakdown of Clostridioides difficile, focusing on the hypervirulent Ribotype 027 strain driving increased hospital morbidity. The episode details the clinical shift away from metronidazole to oral vancomycin or fidaxomicin, and the surprising paradox that mechanical bowel prep with oral antibiotics actually reduces postoperative CDI risk. For surgical management of fulminant colitis, it contrasts the morbidity of the traditional total abdominal colectomy with the colon-preserving loop ileostomy and colonic lavage approach.